Stay updated on Early Switch vs Delayed Nivolumab in Squamous NSCLC Clinical Trial
Sign up to get notified when there's something new on the Early Switch vs Delayed Nivolumab in Squamous NSCLC Clinical Trial page.

Latest updates to the Early Switch vs Delayed Nivolumab in Squamous NSCLC Clinical Trial page
- Check7 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4; no impact on study details or user workflows.SummaryDifference0.0%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check28 days agoNo Change Detected
- Check36 days agoChange DetectedA new Locations section is added with Bologna, Forlì, Lucca, Modena, and Varese; the Bologna, Forlì, Lucca, Modena, and Varese location entries are removed, and the HHS Vulnerability Disclosure footer link is deleted.SummaryDifference0.5%

- Check57 days agoChange DetectedThe Publications section now includes a note that PubMed-sourced publications are automatically filled from PubMed and may not be about the study, replacing the prior wording. The revision tag has been updated from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check65 days agoChange DetectedRemoved the government funding status notice from the EDEN trial page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check86 days agoChange DetectedA new publication entry for the EDEN trial has been added to the Publications section. Other sections of the page, including study design and eligibility criteria, remain the same.SummaryDifference0.3%

- Check109 days agoChange DetectedUpdate includes a critical operating status notice and a new software version (v3.2.0) replacing v3.1.0; the core information about current operations is now different and should be viewed as the authoritative version.SummaryDifference2%

Stay in the know with updates to Early Switch vs Delayed Nivolumab in Squamous NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Early Switch vs Delayed Nivolumab in Squamous NSCLC Clinical Trial page.